KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elevance Health (ELV) Other Accumulated Expenses (2016 - 2025)

Elevance Health (ELV) has disclosed Other Accumulated Expenses for 17 consecutive years, with $12.4 billion as the latest value for Q3 2025.

  • On a quarterly basis, Other Accumulated Expenses fell 18.95% to $12.4 billion in Q3 2025 year-over-year; TTM through Sep 2025 was $12.4 billion, a 18.95% decrease, with the full-year FY2024 number at $10.0 billion, down 37.75% from a year prior.
  • Other Accumulated Expenses was $12.4 billion for Q3 2025 at Elevance Health, down from $17.2 billion in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $17.2 billion in Q2 2025 to a low of $7.7 billion in Q2 2021.
  • A 5-year average of $12.9 billion and a median of $13.0 billion in 2021 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: skyrocketed 137.35% in 2021, then plummeted 37.75% in 2024.
  • Elevance Health's Other Accumulated Expenses stood at $13.5 billion in 2021, then grew by 15.37% to $15.6 billion in 2022, then grew by 3.3% to $16.1 billion in 2023, then tumbled by 37.75% to $10.0 billion in 2024, then increased by 24.02% to $12.4 billion in 2025.
  • Per Business Quant, the three most recent readings for ELV's Other Accumulated Expenses are $12.4 billion (Q3 2025), $17.2 billion (Q2 2025), and $11.4 billion (Q1 2025).